Atara Biotherapeutics Files 8-K
Ticker: ATRA · Form: 8-K · Filed: Jun 17, 2024 · CIK: 1604464
| Field | Detail |
|---|---|
| Company | Atara Biotherapeutics, INC. (ATRA) |
| Form Type | 8-K |
| Filed Date | Jun 17, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, financials
Related Tickers: ATRA
TL;DR
ATRA filed an 8-K, looks like routine docs, no major news yet.
AI Summary
On June 17, 2024, Atara Biotherapeutics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company is incorporated in Delaware and its principal executive offices are located in Thousand Oaks, CA.
Why It Matters
This filing indicates a routine update or submission of financial information and exhibits by Atara Biotherapeutics to the SEC.
Risk Assessment
Risk Level: low — The filing appears to be a standard procedural submission without immediate material news impacting the company's operations or stock.
Key Players & Entities
- Atara Biotherapeutics, Inc. (company) — Registrant
- June 17, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-36548 (identifier) — SEC File Number
- 46-0920988 (identifier) — IRS Employer Identification No.
- 2380 Conejo Spectrum St , Suite 200 Thousand Oaks , CA 91320 (address) — Address of Principal Executive Offices
- (805) 632-4211 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing?
The filing is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, primarily concerning 'Other Events' and 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported is dated June 17, 2024.
What is Atara Biotherapeutics, Inc.'s state of incorporation?
Atara Biotherapeutics, Inc. is incorporated in Delaware.
Where are Atara Biotherapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 2380 Conejo Spectrum St, Suite 200, Thousand Oaks, CA 91320.
What is the SEC file number for Atara Biotherapeutics, Inc.?
The SEC file number for Atara Biotherapeutics, Inc. is 001-36548.
Filing Stats: 654 words · 3 min read · ~2 pages · Grade level 10.7 · Accepted 2024-06-17 08:30:31
Key Financial Figures
- $0.0001 — ich Registered Common Stock, par value $0.0001 per share ATRA The Nasdaq Stock Mar
Filing Documents
- d705331d8k.htm (8-K) — 25KB
- d705331dex991.htm (EX-99.1) — 10KB
- 0001193125-24-162069.txt ( ) — 159KB
- atra-20240617.xsd (EX-101.SCH) — 3KB
- atra-20240617_lab.xml (EX-101.LAB) — 18KB
- atra-20240617_pre.xml (EX-101.PRE) — 11KB
- d705331d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release, dated June 17, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Atara Biotherapeutics, Inc. By: /s/ Amar Murugan Amar Murugan Executive Vice President and Chief Legal Officer Date: June 17, 2024